Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $3.5 billion.

  • Prestige Consumer Healthcare's Liabilities and Shareholders Equity rose 496.31% to $3.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $13.8 billion, marking a year-over-year increase of 375.63%. This contributed to the annual value of $3.4 billion for FY2025, which is 252.53% up from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Liabilities and Shareholders Equity of $3.5 billion as of Q4 2025, which was up 496.31% from $3.4 billion recorded in Q3 2025.
  • Prestige Consumer Healthcare's 5-year Liabilities and Shareholders Equity high stood at $3.7 billion for Q4 2022, and its period low was $3.3 billion during Q2 2024.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $3.4 billion (2021), whereas its average is $3.5 billion.
  • Per our database at Business Quant, Prestige Consumer Healthcare's Liabilities and Shareholders Equity skyrocketed by 703.96% in 2022 and then crashed by 1093.46% in 2023.
  • Prestige Consumer Healthcare's Liabilities and Shareholders Equity (Quarter) stood at $3.7 billion in 2021, then grew by 2.47% to $3.7 billion in 2022, then decreased by 10.93% to $3.3 billion in 2023, then fell by 0.31% to $3.3 billion in 2024, then increased by 4.96% to $3.5 billion in 2025.
  • Its last three reported values are $3.5 billion in Q4 2025, $3.4 billion for Q3 2025, and $3.4 billion during Q2 2025.